ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 778 filers reported holding ASTRAZENECA PLC in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $183,977,362 | -1.9% | 2,716,736 | +3.7% | 1.17% | +8.0% |
| Q2 2023 | $187,572,231 | +69.0% | 2,620,822 | +63.9% | 1.09% | +64.3% |
| Q1 2023 | $110,990,199 | -6.6% | 1,599,052 | -8.8% | 0.66% | -6.6% |
| Q4 2022 | $118,818,822 | +5.2% | 1,752,490 | -14.9% | 0.71% | -3.9% |
| Q3 2022 | $112,908,000 | -19.2% | 2,058,858 | -2.7% | 0.74% | -10.0% |
| Q2 2022 | $139,803,000 | -18.7% | 2,115,989 | -18.4% | 0.82% | -2.8% |
| Q1 2022 | $172,061,000 | +8.2% | 2,593,620 | -5.0% | 0.84% | +4.5% |
| Q4 2021 | $158,965,000 | +57.4% | 2,729,009 | +62.3% | 0.81% | +43.9% |
| Q3 2021 | $100,972,000 | +11.0% | 1,681,188 | +10.7% | 0.56% | +15.0% |
| Q2 2021 | $90,949,000 | +40.1% | 1,518,357 | +16.3% | 0.49% | +60.5% |
| Q1 2021 | $64,923,000 | -12.4% | 1,305,766 | -11.9% | 0.30% | -10.6% |
| Q4 2020 | $74,086,000 | -9.9% | 1,482,025 | -1.3% | 0.34% | -17.1% |
| Q3 2020 | $82,250,000 | -25.9% | 1,500,926 | -28.5% | 0.41% | -28.4% |
| Q2 2020 | $111,011,000 | +15.3% | 2,098,895 | -2.6% | 0.57% | -1.9% |
| Q1 2020 | $96,277,000 | -11.6% | 2,155,763 | -1.3% | 0.58% | +24.3% |
| Q4 2019 | $108,897,000 | -7.1% | 2,184,059 | -17.0% | 0.47% | -12.0% |
| Q3 2019 | $117,258,000 | -21.7% | 2,630,885 | -27.5% | 0.53% | -21.0% |
| Q2 2019 | $149,712,000 | -23.6% | 3,626,722 | -25.1% | 0.68% | -21.0% |
| Q1 2019 | $195,834,000 | -14.5% | 4,843,759 | -19.7% | 0.86% | -19.5% |
| Q4 2018 | $229,094,000 | -23.2% | 6,031,952 | -20.0% | 1.06% | -6.0% |
| Q3 2018 | $298,334,000 | +5.4% | 7,539,385 | -6.5% | 1.13% | +29.5% |
| Q2 2018 | $283,032,000 | -6.6% | 8,061,297 | -7.0% | 0.87% | -18.6% |
| Q1 2018 | $302,998,000 | -3.2% | 8,664,526 | -3.9% | 1.07% | +3.7% |
| Q4 2017 | $312,886,000 | +27.2% | 9,016,879 | +24.2% | 1.04% | +25.7% |
| Q3 2017 | $245,986,000 | -2.6% | 7,260,541 | -2.0% | 0.82% | -3.4% |
| Q2 2017 | $252,624,000 | +5.8% | 7,410,488 | -3.4% | 0.85% | +7.0% |
| Q1 2017 | $238,812,000 | +12.5% | 7,668,993 | -1.3% | 0.80% | 0.0% |
| Q4 2016 | $212,231,000 | -18.6% | 7,768,344 | -2.1% | 0.80% | -18.0% |
| Q3 2016 | $260,765,000 | +10.8% | 7,935,629 | +1.8% | 0.97% | +10.1% |
| Q2 2016 | $235,424,000 | +8.5% | 7,798,058 | +1.2% | 0.88% | +7.7% |
| Q1 2016 | $216,900,000 | -17.2% | 7,702,430 | -0.2% | 0.82% | -21.0% |
| Q4 2015 | $262,104,000 | +7.0% | 7,720,293 | +0.3% | 1.04% | +9.3% |
| Q3 2015 | $245,026,000 | +8.9% | 7,700,378 | +118.0% | 0.95% | +14.2% |
| Q2 2015 | $224,991,000 | +32.7% | 3,531,487 | +42.5% | 0.83% | +31.0% |
| Q1 2015 | $169,579,000 | +75.1% | 2,478,134 | +80.1% | 0.64% | +81.9% |
| Q4 2014 | $96,829,000 | -0.2% | 1,375,798 | +1.3% | 0.35% | -7.7% |
| Q3 2014 | $97,021,000 | +0.7% | 1,358,084 | +4.8% | 0.38% | +0.5% |
| Q2 2014 | $96,339,000 | -55.1% | 1,296,443 | -60.8% | 0.38% | -56.4% |
| Q1 2014 | $214,520,000 | -15.5% | 3,306,417 | -22.7% | 0.86% | -19.6% |
| Q4 2013 | $253,891,000 | +18.6% | 4,276,426 | +3.8% | 1.07% | +12.4% |
| Q3 2013 | $214,038,000 | +43.4% | 4,121,660 | +30.6% | 0.96% | +28.4% |
| Q2 2013 | $149,248,000 | – | 3,155,346 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
| Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
| Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
| SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
| Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
| ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
| Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
| Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
| GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |